Reviews

User Reviews for Tadalafil


Cialis (tadalafil): “Prior to taking cialis getting and maintaining an erection was virtually nonexistent. Cialis brought it all back at the age of 62. Long, thick steel hard erections and works anytime in the 72 hours. It is brought on by the usual foreplay with my wife. Plus multiple spontaneous nocturnal erections during the same time period. Was prescribed 20 mg but cut it to 10 mg after getting leg pain as a side effect. The 10 mg was just as effective as the 20 mg for the desired effect of getting a hard erection. My wife’s reaction speakers volumes of our rekindled sex life. Try it, it works!”

  
9.0

Steelykon (taken for 1 to 2 years) April 24, 2018

 

 

Cialis (tadalafil): “I’m a 53 yr old who was losing full erections. Asked the urologist for some Viagra and he recommended Cialis. I started with 5 mg a day and had unwanted erections all day. Cut my pills in half and loving sex again . Erections rock hard like I was a teenager again! Also increased my urine flow as a bonus. This is a great drug. My Ins pays for most of it but hits me with a $50 copay instead of the usual $20. Money well spent . Highly recommend !!!!”

  
10

Bob (taken for 1 to 6 months) March 24, 2018

“After prostate cancer radiation and seed implants the ability to get erections left after about a year. My urologist started me on Viagra then Levitra and finally Cialis20 mg. I now get partially erect and can reach orgasm without semen.Been doing this for 9 years and am now 81.”

  
6.0

lee (taken for 10 years or more) March 5, 2018

“I have used Tadalafil 10mg for 6 years. Only actually use half a tablet. Works well and does the job. Find 10mg gives me flushed face so that is why I cut back. I always drink a pint of water first. A problem is actual multiple erections the following night which can be annoying but hey. Better than ED.”

  
8.0

JustanotherguywithED (taken for 5 to 10 years) March 3, 2018

“Works fine – but my side effects is blurred vision went to my doctor he told me it was not tadalafil that cause the blur vision, I can’t see in one eye.”

Guy12 February 6, 2018


According to the reviews made by a lot of users who have actually tried this product, Tadacip is an effective product. This product has been designed to combat problems related to erectile dysfunction. However, in order to be safe while taking this product, and in order to achieve the best results, it is highly recommended to discuss with your doctor about it.


We sell many other medicines via our main company website, for example we sell Cenforce 100mg as Generic Viagra, you can check page.

Manufacturer

Who is the Manufacturer of Tadacip?


The manufacturing company behind Tadacip is Cipla. It is a very good alternative for the more popular Cialis brand. This has been particularly designed to provide treatment for erectile dysfunction. Men may not like talking about this particular issue but because it is really a big deal among them, Tadacip was born.

The price of Tadacip may depend on where you are from, but if you are purchasing Tadacip from an online source, you can purchase them depending on the number of pills.

For instance, the price can range from $10 for 20mg 12 pills, to $150 for 20 mg 300 pills. The price may also vary depending on the offer of the online retailer.


Also our company sells anticancers medicines, on of them is Generic Gleevec under brand names: Veenat or Imatib, you can find more information via next link

What is it Tadacip

Cialis: What is it and who can use it?


Here are some key points about Cialis. More detail is in the main article.

  • Under the name Cialis (Tadacip), tadalafil is used to treat erectile dysfunction.
  • As Tadacip, the same drug treats pulmonary arterial hypertension and benign prostatic hyperplasia.
  • Cialis (Tadacip) increases blood flow to the penis, enabling an erection to occur when a man is sexually stimulated.
  • Anyone with a heart condition should seek medical advice before using Cialis (Tadacip).
  • Cialis (Tadacip) is a medication, with potentially serious adverse effects. It should only be obtained from a reputable source and used under medical supervision.

Cialis increases blood flow to the penis, and this enables a man to achieve an erection. It does not lead to sexual arousal. It should be used with caution, and only under medical supervision.

Tadalafil was approved by the United States (U.S.) Food and Drug Administration (FDA) in 2003 for the treatment of erectile dysfunction (ED). It is also used to treat pulmonary arterial hypertension and benign prostatic hyperplasia, a condition in which the prostate gland becomes enlarged, causing problems with urination.


Also we offer interested and popular for brain active medication Modafinil Generic Provigil 200mg, you can order this medication from our company.

Why Tadacip?

Why Cialis ( Tadalafil ) – Tadacip prescribed?


Tadalafil (Cialis) Generic Tadacip is used to treat erectile dysfunction (ED, impotence; inability to get or keep an erection), and the symptoms of benign prostatic hyperplasia (BPH; an enlarged prostate) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency in adult men. Tadalafil (Adcirca) is used to improve the ability to exercise in people with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Tadalafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works to treat erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Tadalafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow more easily.

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age. – See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

If you are taking tadalafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Tadalafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Our company can delivery generic Cialis under brand name Tadacip manufactured by Cipla, it’s best if you would like to receive quality medicines from India.


Also we sell generic valtrex with kind prices. You can use following link to check prices on Valacyclovir 500mg or 1000mg.

 

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α- adrenergic-receptor blockers, 5α-reductase inhibitors, phosphodiesterase-5 inhibitor therapy, and antimuscarinic therapy. Read the latest Clinical Practice article on this topic. BPH, a histologic diagnosis, is a condition that occurs with aging; the prevalence increases from 25% among men 40 to 49 years of age to more than 80% among men 70 to 79 years of age.

Clinical Pearls

What are the lower urinary tract symptoms associated with BPH?

The symptoms are classified as obstructive voiding or bladder storage symptoms. Obstructive voiding symptoms include urinary hesitancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. Storage symptoms include urinary frequency, nocturia, urgency, incontinence, and bladder pain or dysuria.

What are the risk factors for developing BPH?

In addition to increased age, additional risk factors include black (vs. white) race, obesity, diabetes, high levels of alcohol consumption, and physical inactivity; mechanisms underlying these associations remain poorly understood. Physiological markers associated with an increased risk of benign prostatic hyperplasia include levels of endogenous testosterone and dihydrotestosterone as well as increased levels of dehydroepiandrosterone and estradiol, insulin-like growth factors, and inflammatory markers (e.g., C-reactive protein).

– See more at: http://blogs.nejm.org/now/index.php/bph/2012/07/20/#sthash.9rzScxeD.dpuf

Study

Study: Cialis (Tadalafil) Does Not Prevent Erectile Dysfunction in Prostate Cancer Patients


Article date: April 4, 2014

By Stacy Simon

Researchers from the Mayo Clinic and colleagues across the United States and Canada have found that Cialis (tadalafil) does not help men avoid erectile dysfunction after radiation therapy for prostate cancer. Erection problems are common in men who’ve been treated for prostate cancer, and the rates reported in Sorafenib the medical literature vary widely. According to background information in the study published in the April 2 issue of the Journal of the American Medical Association, about 40% of men report erectile dysfunction after radiation therapy.

One way that radiation affects erections is by damaging the arteries that carry blood to the penis. As the treated area heals, the blood vessels lose their ability to stretch due to scar tissue in and around the vessels. They can no longer expand as much as is necessary to let in enough blood for an erection. Radiation may also affect the nerves that control a man’s ability to have an erection.

Cialis is a pill that works by increasing blood to flow to the penis. It is sometimes prescribed to men with erectile dysfunction after radiation treatment, but the researchers wanted to find out whether taking Cialis once a day could prevent erectile dysfunction from occurring if it was begun when radiation started.

They randomly assigned 242 patients with early stage prostate cancer to receive daily doses of Cialis or a placebo (sugar pill). The men started the Suhagra drug within a week of starting radiation and continued for 24 weeks. They found that between 28 and 30 weeks after the start of radiation therapy, 79% of those taking Cialis were able to maintain erectile function compared with 74% of those  taking the placebo – not a significant difference. After a year, 72% of men who took Cialis and 71% of those who took the placebo were able to maintain an erection. Overall, Cialis was not associated with improvement in overall sexual function and the partners of men who took Cialis in the study did not report a significant effect on sexual satisfaction.

The authors concluded that taking Cialis every day does not prevent erectile dysfunction in prostate cancer patients being treated with radiation, and other strategies should be explored. This may include different dosing, further refinements of radiation delivery methods, and other treatments that are available to help with erection problems.

Citation: Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer. Published in the April 2, 2014 issue of the Journal of the American Medical Association. First author Thomas M. Pisansky, MD, Mayo Clinic, Rochester Minn.


Many peoples also was interested in buying generic lyrica (pregabalin) from india, you can check prices on it, via following link.

Tadalafil Fron Cipla Ltd. is indicated for the treatment of men with erectile dysfunction (ED), men with the signs and symptoms of benign prostatic hyperplasia (BPH)